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A phytochemical study has been carried out on the surface exudate of Salvia x jamensis, which showed a significant platelet 
antiaggregating activity. The known compounds isopimaric acid (2), 14-α-hydroxy-isopimaric acid (3), 3β-hydroxy-isopimaric 
acid (4), 7,8β-dihydrosalviacoccin (5), betulinic acid (6), and ursolic acid (7) were isolated together with the new diterpene 1. 
The structure of 1 was determined as 15,16-epoxy-cleroda-3-en-7α,10β-dihydroxy-12,17;19,18-diolide on the basis of 
spectroscopic data analysis. Among all tested compounds, 2 showed a significant concentration-dependent antiaggregating 
activity when ADP (3 µM) was used as agonist on rat platelets. Conversely, 1 increased ADP–induced platelet aggregation. 
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Platelet aggregation inhibitors are widely used in 
thromboembolic diseases. Since the currently 
available compounds have various limitations, it is 
desirable to find new types of platelet antiaggregating 
agents, which prevent the initiation of thrombus 
formation. The surface exudate of Salvia x jamensis 
J. Compton, obtained by rinsing the plant material 
with methylene chloride, showed a concentration– 
dependent trend toward platelet antiaggregating 
activity. 
 
Repeated column chromatography on Sephadex    
LH-20 and silica gel of the surface exudate of aerial 
parts of S. x jamensis  yielded one new diterpenoid 
(1), four known diterpenoids (2-5) and two known 
triterpenoids (6-7). 
 
IR absorption bands at 3540 (OH), 1760, 1700 (two 
lactone rings), and 3140, 1505, 875 (β-substituted 
furan ring) cm-1 and 20 carbon resonances in the 13C 
NMR spectrum (Table 1) suggested that 1 had an 
oxygenated clerodane diterpenoid structure. From the 
TOCSY, HSQC,  and  HMBC spectral data (CD3OD) 
 
 
Figure 1: Structure of compound 1. 
 
the partial structures I: -CH2-CH2-CH=C(CO)-
C(CH2)-C- [δC = 25.9, 23.8, 136.3, 139.1, 172.0, 
48.5, 75.9, 76.7]; II: -CH2-CH-CH-C(CH3)- [δC = 
31.7, 67.3, 46.8, 43.5, 23.1]; and III: -CH2-CH-
C(=CH)-CH=CH- [δC = 41.3, 73.0, 125.8, 141.4, 
109.8, 145.1] were established. The partial structure I 
was put in the A and 19,18-olide rings and its carbon 
signals assigned to C-1, -2, -3, -4, -18, -5, -19, and     
-10, respectively, on the basis of the following 
HMBC correlations: δC = 76.7 (C-10) / δH 1.81 (H2-
1),  δC = 48.5 (C-5) / δH = 5.49 (Hexo-19),  1.81 (H2-1) 
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Table 1: NMR spectral data for compound 1: δ values, CD3OD [CDCl3], 13C NMR at 150 MHz, 1H NMR at 600 MHz. 
_______________________________________________________________________________________________________________________ 
C 13C  DEPT  1H (J in Hz)      HMBC correlations of the C 
________________________________________________________________________________________________________________________________ 
 
1   25.9 [26.4] CH2 1.81 m [1.72 m; 1.82 ddd (3.3, 3.3, 13.4) eq]               2.63, 6.68 
2   23.8 [22.4] CH2 2.35, 2.63 both m [2.54 m]     1.81, 6.68 
3 136.3 [133.4] CH 6.68 m [6.72 dd (3.0, 6.0)]     1.81, 2.35, 2.63 
4 139.1 [139.2] C -       2.35, 2.63, 5.49 
5   48.5 [48.1] C -       1.81, 2.01, 5.49, 6.68 
6   31.7 [30.9] CH2 2.01, 2.28 both m [2.16 ddd (2.4, 3.0, 14.4) ax; 2.23 dd (1.7, 14.4) eq]          3.99, 5.49 
7   67.3 [65.9] CH 4.60 br s [4.65 br s]          2.01, 3.79 
8   46.8 [45.6] CH 3.79 d (3.3) [3.58 d (3.1)]        1.19, 1.70, 2.01 
9   43.5 [41.5] C -       1.19, 1.70, 2.70, 3.79 
10   76.7 [76.5] C -       1.19, 1.81, 2.70 
11   41.3 [40.5] CH2 1.70 dd (11.5, 13.9) [1.65 dd (11.3, 13.6) ax] 
     2.70 dd (6.1, 13.9) [2.74 dd (6.2, 13.6) eq]               1.19, 3.79 
12   73.0 [71.9] CH 5.44 dd (6.1, 11.5) [5.34 dd (6.2, 11.3)]               1.70 
13 125.8 [124.1] C -       1.70, 5.44, 6.58, 7.57, 7.65 
14 109.8 [108.9] CH 6.58 br s [6.48 br s]      5.44, 7.57, 7.65 
15 145.1 [144.1] CH 7.57 br s [7.47 br s]      6.58, 7.65 
16 141.4 [140.0] CH 7.65 br s [7.51 br s]      5.44, 6.58, 7.57 
17 178.5 [176.3] C -       3.79 
18 172.0 [168.7] C -       5.49, 6.68 
19   75.9 [74.6] CH2 3.99 dd (2.4, 7.1), 5.49 d (7.1) [3.88 dd (2.4, 7.3) endo, 5.49 d (7.3) exo]      2.01, 2.28 
20   23.1 [22.9] CH3 1.19 s [1.21 s]      1.70, 2.70, 3.79 
_________________________________________________________________________________________________________________ 
 
and 6.68 (H-3); δC = 172.0 (C-18) / δH = 5.49     
(Hexo-19) and 6.68 (H-3). The partial structure II was 
put in ring B and its carbon signals assigned to C-6,   
-7, -8, -9, and -20, respectively on the basis of the 
following HMBC correlations: δC = 48.5 (C-5) / δH = 
2.01 (Ha-6); δC = 76.7 (C-10) with the signals / δH = 
1.19 (CH3-20) and 2.70 (Ha-11). The carbon signals 
of the partial structure III were assigned to C-11, -12, 
-13, -16, -14, and -15 respectively, on the basis of the 
following HMBC correlations: δC = 41.3 (C-11) / δH= 
1.19 (CH3-20), δC = 43.5 (C-9) / δH = 1.70 and 2.70 
(CH2-11), δC = 46.8 (C-8) / δH = 1.70 (Hb-11), δC = 
125.8 (C-13), 109.8 (C-14), 141.4 (C-16) / δH = 5.44 
(H-12). The signal at δC = 178.5 was assigned to     
C-17 of a 12,17-olide ring by its HMBC correlation 
with the signal at δH = 3.79 (H-8). The axial 
orientation of the hydroxyl group at C-7 was 
indicated by the small J value of H-7. The strong 
deshielding effect on the exo H-19 (δH = 5.49) as 
compared to the endo H-19 (δH = 3.99 or 3.88 in 
CD3OD or CDCl3), which showed the expected        
W coupling (2.4 Hz) with H-6 β axial [1], the 
downfield shift of CH3-20 (0.36 ppm in CDCl3) in 1 
compared to that of bacchotricuneatin A, which lacks 
the -OH group on C-7 [2], and ROESY correlation 
(CDCl3) CH3-20 / CH2-19 showed that these last 
groups and 7-OH are on the same α side. From its 
coupling constants, H-12 resulted as axial. ROESY 
correlations H-6 β axial / H-8, and H-8 / H-12 axial 
showed that these protons are on the same β side. 
ROESY correlations (CDCl3) of H-1 α-axial with 
CH3-20 and H-19 endo could be explained with a  
5α, 10β trans-fused structure and thus with a            
β orientation of the 10-OH. From these results,          
1 is 15,16-epoxy-cleroda-3-en-7α,10β-dihydroxy-
12,17;19,18-diolide.  
 
The known compounds 2-6 were identified as 
isopimaric acid [3], 14α-hydroxy-isopimaric acid, 
3β-hydroxy-isopimaric acid [4], 7,8β-dihydro-
salviacoccin [5], and betulinic acid [6], respectively 
by comparison of their physical and spectroscopic 
data with those published in the literature. Compound 
7 was identified as ursolic acid by comparison (TLC, 
IR) with an authentic sample. 
 
The crude surface exudate from the aerial part of 
Salvia x jamensis, showed, at a concentration of 100 
–1000 µg/mL, a trend toward platelet anti-
aggregating activity (data not shown). Compound 2 
(HPLC analysis: one single peak), at concentrations 
of 6x10-4 and – 10-3M, inhibited significantly ADP   
(3 µM)–induced platelet aggregation. Compounds      
3–4 did not modify platelet aggregation in a 
significant manner. On the contrary, compound 1 
(HPLC analysis: one single peak) increased, at the 
highest concentration, ADP-induced platelet 
aggregation (Table 2).  
 
The observed trend toward the platelet anti-
aggregating effect of the surface exudate of Salvia x 
jamensis is likely due to the presence of the active 
compound 2;  however,  compound 3 (HPLC analysis 
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Table 2: Anti-aggregating activity of the isolated compounds. 
Results are expressed as mean ± S.E. and represent aggregation (%) in 
response to ADP 3 µM. In brackets are reported concentrations (M) of 
compounds tested. Vehicle (DMSO) value was 27.9 ± 2.8 %. ** p< 0.01 
one way ANOVA followed by Dunnett’s test vs. vehicle (n = 10). 
 
indicated that the compound was 97% pure) showed 
an inhibitory trend, although not significant. It is 
worth noting that compound 3 in comparison with 2 
differs by the presence in the molecule of an 
hydroxyl group; this suggests that the reduced 
activity could be due to reduced lipophylicity. 
Compound 4 (HPLC analysis: one single peak), an 
isomer of 3, had lost the observed biological activity. 
Compounds 5–7 were completely inactive (data   not 
shown). The inactivity of compound 7 on ADP–
induced platelet aggregation has already been 
described in the literature [7]. In a previous paper [8], 
inhibition of platelet aggregation by diterpenes of the 
pimarane and abietane groups was also described. All 
these results may suggest the possibility that 
pimarane, isopimarane and abietane derivatives may 
be useful for semisynthesis of new compounds with 
platelet antiaggregating activity. 
 
Experimental 
General experimental procedures: Melting points 
are uncorrected and were measured on a Tottoli 
melting point apparatus (Büchi). Sephadex LH-20 
(Pharmacia) and silica gel 60 (Merck 230-400 mesh) 
were used for column chromatography; aluminium 
sheets of silica gel 60 F254 (Merck 0.2 mm thick) with 
CHCl3/MeOH/HCOOH (10: 0.5: 0.1) as eluent were 
used for TLC, and the spots were detected by 
spraying with 50% H2SO4, followed by heating. 
Analytical HPLC was performed using a Waters 
model W600 pump equipped with a Rheodyne 
Waters Delta 600 Injector and a Model 2414 
Refractive Index detector (Waters Corporation, 
Milford, USA); results were analyzed using Waters 
Empower software.  
 
An injection vol. of 20 μL was used with a Merck 
LiChrospher 100 RP-18 end-capped column (5 μm, 
250 x 4.5 mm). The elution mixture was composed of 
CH3CN/H2O 75:25. UV spectra were obtained with a 
diode array HP 8453 spectrophotometer (Hewlett 
Packard, USA). IR spectra were recorded on a 
Perkin-Elmer 1310 spectrophotometer. ESIMS 
(positive mode) were obtained from a LCQ 
Advantage Thermo Electron spectrometer, equipped 
with Xcalibur software. NMR spectra were recorded 
on a Bruker DRX 600 spectrometer  (600 MHz for 1H 
and 150 MHz for 13C) in CDCl3 using TMS as 
internal standard. The optical rotation was recorded 
on a Perkin-Elmer 241MC polarimeter. 
 
Plant material: Aerial parts of S. x jamensis J. 
Compton were obtained from Istituto Sperimentale 
per la Floricoltura (Sanremo, Italy) and Centro 
Regionale di Sperimentazione ed Assistenza Agricola 
(Albenga. Italy). The plant was identified by           
Dr Gemma Bramley and a voucher specimen is 
deposited in Kew Herbarium (K). 
 
Extraction and isolation: For the isolation of leaf 
surface constituents, fresh aerial parts (3.1 kg) were 
immersed in CH2Cl2 for 20 sec. After filtration the 
extraction solvent was removed under reduced 
pressure. The exudate (18 g) was chromatographed in 
portions of 1.5 g on Sephadex LH-20 columns (60 x 
3 cm) using CHCl3/MeOH (7:3) as eluent to give, in 
order of elution, fractions (3 g) containing waxy 
compounds (170 mL), fractions (3 g) with very crude 
7 (from 170 mL to 220 mL) and fractions  (12 g) with 
a mixture of 1-7 (from 220 mL to 290 mL). These 
last fractions groups were chromatographed in 
portions of 4 g on silica gel columns (40 x 4 cm) 
eluting with mixtures of n-hexane- CHCl3 [50:50 (4.1 
L), 40:50 (2.1 L), 33:67 (1.0 L), 25:75 (1.0 L), 10:90 
(11.0 L)], then with CHCl3 (8.3 L), and then with 
CHCl3-MeOH [95:5 (3.4 L)]. Elution with n-hexane-
CHCl3 40:50 (from 0.2 L to 2.1 L) and with              
n-hexane-CHCl3 33:67 and 25:75 afforded fractions 
with 2 (crystallized from MeOH: 2.05 g). Elution 
with n-hexane-CHCl3 10:90 afforded first fractions 
with 6 (from 1.0 to 1.4 L; crystallized from EtOH: 
0.2 g), then fractions with 7 (from 1.6 to 2.7 L; 
crystallized from EtOH: 1.4 g), then fractions with 5 
(from 2.7 to 3.0 L; crystallized from CHCl3/MeOH: 
0.14 g), then with 1 (from 3.8 to 11.0 L; crystallized 
from CHCl3/MeOH: 0.58 g). Elution with CHCl3 
afforded fractions with 3 (from 3.5 to 6.0 L; 
crystallized from MeOH/H2O: 0.25 g). Elution with 
CHCl3-MeOH 95:5 afforded fractions with 4 (from 
1.1 to 2.0 L, crystallized from MeOH/H2O: 50 mg).  
 
Compound 1 
MP: 229-230ºC (dec.). 
[α]D25: -76.0 (c 1.00, CHCl3). 
aggregation % 
Compound (2 x 10 -4) (6 x 10 -4) (10 -3)  
1 48.1 ± 14.1 29.8 ± 7.1 62.7 ± 8.9 ** 
2 18.4 ± 2.9   5.4 ± 3.1 **   2.3 ± 1.3 ** 
3 33.6 ± 9.0 21.0 ± 4.6 16.7 ± 4.0 
4 46.7 ± 3.3 34.6 ± 5.1 22.4 ± 3.7 
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Rf : 0.30. 
IR (KBr): 3540, 3140, 3010, 1760, 1700, 1600, 1505, 
875 cm-1. 
UV/Vis λmax (MeOH) nm (log ε): 209 (4.11), 242 
(2.97). 
1H NMR: Table 1. 
13C NMR: Table 1. 
ESIMS (positive mode): m/z 375 [M+H]+. 
Anal. Calcd. for C20H22O7: C, 64.16; H, 5.92. Found 
C, 64.21; H, 5.92. 
 
Platelet preparation and aggregation: Blood was 
withdrawn by cardiac puncture from male Wistar rats 
(Harlan - Nossan, 200-250 g), slightly anesthetised 
with enflurane, and anticoagulated with 3.8 % (w/v) 
trisodium citrate (1:9 v/v). Platelet-rich plasma (PRP) 
and platelet-poor plasma (PPP) were prepared as 
previously described [9]. Platelet count in PRP was 
adjusted to 3x105 platelets µL-1 with autologous PPP. 
Platelet aggregation was monitored in an Elvi 840 
light transmission aggregometer by measuring 
changes in turbidity of 0.25 mL PRP warmed at 37°C 
and under continuous stirring.  After preliminary 
experiments, the concentration of 3 μM ADP was 
chosen and used throughout all the study. 
 
To evaluate the effect of compounds 1-7 on        
ADP-induced platelet aggregation, 5 µL of each 
compound tested, was added to PRP 5 min before the 
ADP (3 µM) at a final concentrations ranging 
between 2 x  10-4 and 10-3 M. As control, an equal 
volume of DMSO (dimethylsulfoxide) was added to 
PRP. 
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